ECCO European Cancer Summit 2019

12 September 2019


All.Can Steering Committee member Kathy Oliver, will be presenting finding from the Al.Can patient survey at the European CanCer Organisation (ECCO) 2019 European Cancer Summit in Brussels on 12 September.

ICHOM 2019 Conference

2 May 2019

Rotterdam, Netherlands

Suzanne Wait will be chairing a session at the annual ICHOM conference titled 'Applications of the ICHOM - All. Can Value in Breast and Lung cancer study' on 2 May.

ESMO 2018 Congress: ICHOM – All.Can

20 October 2018

Munich, Germany

ICHOM–All.Can presented a poster entitled 'Improving Value in Cancer Care study: A European study of outcomes in practice' at the annual ESMO Congress 2018.

All.Can at European Health Forum Gastein 2018

4 October 2018

Bad Hofgastein, Austria

All.Can hosted its second session at the European Health Forum Gastein (EHFG).

All.Can member presents patient perspectives at ECCO Summit

8 September 2018


All.Can Steering Committee member Kathy Oliver discussed interim findings from the All.Can patient survey at the European CanCer Organisation (ECCO) 2018 European Cancer Summit in Vienna on 8 September.

ICHOM – All.Can ‘Improving value’ study launched at Madrid event

18 June 2018

Madrid, Spain

All.Can has partnered with the International Consortium for Health Outcomes Measurement (ICHOM) to undertake a landmark study in lung and breast cancer, which officially launched today on 18 June, with a launch event in Madrid.

MEPs Against Cancer seminar

30 January 2018

Brussels, Belgium

Lieve Wierinck MEP hosted a seminar with MEPs Against Cancer (MAC) at the European Parliament on 30 January 2018.

MEPs Against Cancer seminar to take place in January

30 January 2018

European Parliament, Brussels

The seminar will provide an opportunity to present concrete examples of programmes and initiatives that have improved efficiency in cancer care.

IBTA World Summit 2017

19 October 2017

London, England

At the third Biennial World Summit of Brain Tumour Patient Advocates on 19–22 October 2017, run by the International Brain Tumour Alliance (IBTA), All.Can held a masterclass with 90 brain tumour patient advocates, patients and carers from around the world.